CN103142959A - Medicament for treating urticaria - Google Patents
Medicament for treating urticaria Download PDFInfo
- Publication number
- CN103142959A CN103142959A CN 201310090389 CN201310090389A CN103142959A CN 103142959 A CN103142959 A CN 103142959A CN 201310090389 CN201310090389 CN 201310090389 CN 201310090389 A CN201310090389 A CN 201310090389A CN 103142959 A CN103142959 A CN 103142959A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- fructus
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating urticaria. The medicament is prepared from the following substances in a weight proportion: 5-10 parts of figwort roots, 10-20 parts of dried ginger, 20-30 parts of common macrocarpium fruits, 10-20 parts of platycodon roots, 15-25 parts of dahurian angelica roots, 5-15 parts of inula flowers, 10-30 parts of cowherb seeds, 1-15 parts of dutchmanspipe vines, 10-20 parts of divaricate saposhnikovia roots, 15-30 parts of ephedra herbs, 20-30 parts of belleric terminalia fruits, 1-20 parts of morinda officinalis, 1-20 parts of greater celandine herbs, 10-25 parts of lalang grass rhizomes, 10-30 parts of siberian cocklour fruits, 1-20 parts of emblic leafflower fruits, 15-20 parts of cablin potchouli herbs, 10-20 parts of glossy privet fruits, 15-20 parts of stachyurus, 15-30 parts of garden euphorbia herbs, 10-20 parts of Chinese clinopodium herbs, 10-25 parts of senna leaves, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury roots, 15-25 parts of dahurian rhododendron leaves, 15-25 parts of discolor cinquefoil herbs, 10-20 parts of franchet groundcherry calyx and fruits, 15-25 parts of white mulberry root-barks, 20-30 parts of lindley eupatorium herbs, 1-20 parts of teasel roots and 10-25 parts of Chinese azalea flowers. All components of the medicament for treating urticaria are natural materials, so that the medicament is good in security, obvious in curative effect and clinically suitable for large-scale popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of urticaria.
Background technology
Urticaria is called again urticaria, it is the local edema with skin one property crossed of pruritus, outbreak repeatedly, be the effect with the master's of histamine various chemical mediators that the fertile cell of corium discharges, cause the dermatosis erythra of capillary permeability due to the increasing course of disease of repeatedly showing effect to surpass the January person and claim chronic urticaria, its cause of disease is complicated, delay is difficult, especially the child suffers from this after being ill, is unfavorable for long-term taking antihistamine drug, therefore very thorny on clinical treatment.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of urticaria.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of urticaria, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Herba Pogostemonis 15-20 part, Fructus Ligustri Lucidi 10-20 part, Medulla Stachyuri (Medulla Helwingiae) 15-20 part, Ramulus et Folium Bauhiniae Faberi 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
preferably, the medicament for the treatment of urticaria of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Herba Pogostemonis, 17 parts of Fructus Ligustri Lucidi, 19 parts of Medulla Stachyuri (Medulla Helwingiae)s, 15 parts of Ramulus et Folium Bauhiniae Faberi, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of urticaria of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, the Radix Angelicae Dahuricae 21 grams, Flos Inulae 13 grams, Semen Vaccariae 28 grams, Herba Aristolochiae 11 grams, Radix Saposhnikoviae 17 grams, Herba Ephedrae 24 grams, Fructus Terminaliae Billericae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Herba Pogostemonis 16 grams, Fructus Ligustri Lucidi 17 grams, Medulla Stachyuri (Medulla Helwingiae) 19 grams, Ramulus et Folium Bauhiniae Faberi 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Folium Rhododendri Daurici 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Cortex Mori 25 grams, Herba Eupatorii Lindleyani 26 grams, Radix Dipsaci 16 grams and Flos Rhododendri Mollis 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
This group of clinical data case 60 examples, male 30 examples wherein, female's 30 examples; 25～45 years old age, average 32 years old.Diagnostic criteria with reference to " traditional Chinese medical science disease Standardization of diagnosis and curative effect " (ZY/T001.8-94) [State Administration of Traditional Chinese Medicine, disease of tcm diagnostic criteria [s]. Nanjing: publishing house of Nanjing University, 2006:147].1. outbreak repeatedly, skin lesion be differ in size, edema speckle that shape differs, boundary is clear.2. time-out disappears during erythra, and single skin lesion disappears and is no more than 24h, violent pruritus, and skin lesion appearing without definite location leaves no trace after disappearing.3. some cases can have abdominal pain diarrhea or respiratory symptom.4. erythra is shown effect repeatedly, through the person of not healing more than March.5. dermatograph test is positive.
Use the decoction of preparation in embodiment 1 to treat, every day 2 times, each oral 50 milliliters, treating January is a course for the treatment of.
According to People's Republic of China's Chinese medicine industry standard, the efficacy evaluation of TCM Dermatology disease Standardization of diagnosis and curative effect [State Administration of Traditional Chinese Medicine. People's Republic of China's Chinese medicine industry standard. traditional Chinese medical science disease Standardization of diagnosis and curative effect [M]. Nanjing: publishing house of Nanjing University, 2004].Cure: welt disappears, and clinical sign disappears, and the person does not reaccess; Take a turn for the better: welt disappears 30%, or the rear recurrent interval time that disappears extends, and the sx↓ person such as scratch where it itches; Do not heal: welt and the obviously improver of nothing that scratches where it itches, or the less than 30% that disappears.
Through the treatment of a course for the treatment of, find to have and cure 56 examples in 60 patients, 4 examples take a turn for the better.
Claims (3)
1. medicament for the treatment of urticaria, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Radix Angelicae Dahuricae 15-25 part, Flos Inulae 5-15 part, Semen Vaccariae 10-30 part, Herba Aristolochiae 1-15 part, Radix Saposhnikoviae 10-20 part, Herba Ephedrae 15-30 part, Fructus Terminaliae Billericae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Herba Pogostemonis 15-20 part, Fructus Ligustri Lucidi 10-20 part, Medulla Stachyuri (Medulla Helwingiae) 15-20 part, Ramulus et Folium Bauhiniae Faberi 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Folium Rhododendri Daurici 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Cortex Mori 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Radix Dipsaci 1-20 part and Flos Rhododendri Mollis 10-25 part.
2. the medicament for the treatment of urticaria according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of the Radixs Angelicae Dahuricae, 13 parts of Flos Inulaes, 28 parts of Semen Vaccariae, 11 parts of Herba Aristolochiaes, 17 parts of Radix Saposhnikoviaes, 24 parts, Herba Ephedrae, 27 parts of Fructus Terminaliae Billericaees, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Herba Pogostemonis, 17 parts of Fructus Ligustri Lucidi, 19 parts of Medulla Stachyuri (Medulla Helwingiae)s, 15 parts of Ramulus et Folium Bauhiniae Faberi, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Folium Rhododendri Daurici, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Cortex Mori, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Radix Dipsacis and Flos Rhododendri Mollis.
3. the medicament for the treatment of urticaria according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310090389 CN103142959A (en) | 2013-03-21 | 2013-03-21 | Medicament for treating urticaria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201310090389 CN103142959A (en) | 2013-03-21 | 2013-03-21 | Medicament for treating urticaria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103142959A true CN103142959A (en) | 2013-06-12 |
Family
ID=48541468
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201310090389 Pending CN103142959A (en) | 2013-03-21 | 2013-03-21 | Medicament for treating urticaria |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142959A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393834A (en) * | 2013-08-05 | 2013-11-20 | 谢明臣 | Prescription for treatment of urticaria |
| CN103860977A (en) * | 2014-03-24 | 2014-06-18 | 黄文超 | Drug composition for treating dermatitis |
| CN103860976A (en) * | 2014-03-24 | 2014-06-18 | 李周全 | Drug composition for treating infantile dermatitis |
| CN103989974A (en) * | 2014-03-21 | 2014-08-20 | 张春玲 | Foot bath traditional Chinese medicine for treating specific endowment constitution and preparation method thereof |
-
2013
- 2013-03-21 CN CN 201310090389 patent/CN103142959A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393834A (en) * | 2013-08-05 | 2013-11-20 | 谢明臣 | Prescription for treatment of urticaria |
| CN103989974A (en) * | 2014-03-21 | 2014-08-20 | 张春玲 | Foot bath traditional Chinese medicine for treating specific endowment constitution and preparation method thereof |
| CN103860977A (en) * | 2014-03-24 | 2014-06-18 | 黄文超 | Drug composition for treating dermatitis |
| CN103860976A (en) * | 2014-03-24 | 2014-06-18 | 李周全 | Drug composition for treating infantile dermatitis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103341145A (en) | Traditional Chinese medicine for treating psoriasis and preparation method thereof | |
| CN103157087A (en) | Drug for treating femoral head necrosis | |
| CN103142959A (en) | Medicament for treating urticaria | |
| CN103100075B (en) | Medicament for treating eczema | |
| CN102204983B (en) | Medicament for treating urticaria | |
| CN101912577B (en) | Medicament for treating rheumatism and rheumatoid disease and preparation process | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN102949700A (en) | Chinese medicinal preparation for treating cold stuffy nasal obstruction | |
| CN101940752A (en) | Chinese medicinal decoction for treating acute radiation proctopathy | |
| CN104587267A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN101843861B (en) | Chinese medicinal composition for treating tonsillitis | |
| CN102294007A (en) | Medicament for treating urticaria | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN103142972B (en) | Medicine for treating children dermatosis | |
| CN103157084A (en) | Drug for treating osteoporosis | |
| CN103566219A (en) | Traditional Chinese medicine composition for treating cold | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN103272192B (en) | Medicament for treating perianal abscess | |
| CN103142958A (en) | Medicament for treating perniosis | |
| CN103157090A (en) | Medicament for treating diarrhea | |
| CN103948894B (en) | A kind of preparation method of nursing the medicament for the treatment of cesarean postoperate FUO | |
| CN103157091A (en) | Drug for treating empyrosis | |
| CN106177686A (en) | A kind of Chinese medicine for treating urticaria | |
| CN105582187A (en) | Traditional Chinese medicine composition formula for preventing and treating allergic dermatitis | |
| CN103142960B (en) | Medicament for treating skin diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130612 |